Drug Discovery Services Market Size Worth USD 75.13 Billion By 2034 | CAGR: 14.6%
The drug discovery services market size is expected to reach USD 75.13 billion by 2034, according to a new study by Polaris Market Research. The report “Drug Discovery Services Market Size, Share, Trends, Industry Analysis Report: By Process, Type (Chemistry Services and Biology Services), Drug Type, Therapeutic Area, End User, and Region – Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Drug discovery services are the research and development services offered to pharmaceutical, biotech, and life science companies to help discover new drug candidates. The services offered span different aspects of drug development, including target identification, lead discovery, hit-to-lead optimization, preclinical development, and candidate validation. The main objective of drug discovery services is to discover new potential therapeutic compounds and optimize them before entering clinical trials.
The market for drug discovery services is growing rapidly due to several factors, including the rising complexity of drug development, the growing prevalence of chronic diseases, and the increasing need for novel drugs. One of the major trends in the drug discovery services market is the outsourcing of research work to contract research organizations (CROs). This is because it allows pharmaceutical and biotechnology companies to reduce costs and accelerate drug development.
Lead optimization is the foremost growing segment of the drug discovery service market. This expansion is attributed to the rising emphasis on optimizing drug leads to increase their potency and safety before embarking on clinical trials. Additionally, the target selection segment remains the leader due to its paramount importance in selecting the best drug target during the initial stages of drug development.
Chemistry services currently dominate the market and provide an important support function in drug synthesis and early biological data. Biology services are also projected to grow at the highest rate because biological knowledge plays an important role in the development of biologics and personalized medicine.
Pharmaceutical and biotech companies lead the market. This is because they are heavily investing in research to develop drugs and treatments. Also, the educational institutes category is expanding rapidly as more partnerships are formed among prominent market players.
New technologies, including artificial intelligence, machine learning, and gene editing techniques such as CRISPR, are revolutionizing drug development. They are making it possible to identify potential drug molecules quickly and easily. Opportunities exist in the growing fields of personalized medicine, biologics, and gene therapies. Collaborations, the growing interest in new therapeutic areas, and the need for high-quality customized solutions in the drug development process also fuel the drug discovery services market.
Where Is the Market Headed?
More companies have started outsourcing to access specialized platforms such as high-throughput screening, advanced cell models, and bioinformatics. Outsourcing is helping companies accelerate discovery timelines and run multiple programs at the same time. North America currently leads the drug discovery services market, mainly due to a strong pharmaceutical industry and technological developments. Asia Pacific is expected to be the fastest-growing region, driven mainly by investments in infrastructure development and the growing number of countries outsourcing drug discovery services.
What Does Drug Discovery Services Report Reveals?
- What is the global market size and CAGR for the market during 2026–2034?
- Which factors are contributing to the industry expansion?
- Who are the key industry players? What is their relative position in terms of competitive positioning?
- How do different service types, such as chemistry services and biology services, influence the market landscape?
- How does the market differ in terms of process, type, drug type, therapeutic area, end user, and geography? Which is the leading end user?
- What are the opportunities in different regional markets, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa?
- What are the emerging technologies and innovations in the market?
Request a free sample copy or read the full market insights: Drug Discovery Services Market
Polaris Market Research has segmented the drug discovery services market on the basis of process, type, drug type, therapeutic area, end user, and region:
By Process Outlook (Revenue, USD Billion, 2021–2034)
- Target Selection
- Target Validation
- Hit-To-Lead Identification
- Lead Optimization
Candidate Validation
By Type Outlook (Revenue, USD Billion, 2021–2034)
- Chemistry Services
- Biology Services
By Drug Type Outlook (Revenue, USD Billion, 2021–2034)
- Small Molecules
- Biologics
By Therapeutic Area Outlook (Revenue, USD Billion, 2021–2034)
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Neurological Diseases
- Immunological Diseases
- Digestive & Gastrointestinal Diseases
- Genitourinary & Women’s Health
- Respiratory Diseases
- Endocrine & Metabolic Diseases
- Other Therapeutic Areas
By End User Outlook (Revenue, USD Billion, 2021–2034)
- Pharmaceutical & Biotechnology Companies
- Academic Institutes
- Others
By Regional Outlook (Revenue, USD Billion, 2021–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
